Comparing dermatologic patient-reported outcome measures in cutaneous lupus erythematosus

Lupus Sci Med. 2022 Dec;9(1):e000827. doi: 10.1136/lupus-2022-000827.

Authors

Grant Sprow^{1

2}, Joshua Dan^{1

2}, Rui Feng³, Victoria P Werth^{4

2}

Affiliations

¹ Dermatology, Corporal Michael J Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA.
² Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
³ Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁴ Dermatology, Corporal Michael J Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA werth@pennmedicine.upenn.edu.

No abstract available

Keywords: Autoimmune Diseases; Outcome Assessment, Health Care; Quality of LIfe.

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

Humans
Lupus Erythematosus, Cutaneous* / diagnosis
Lupus Erythematosus, Systemic*
Patient Reported Outcome Measures

Grants and funding

R01 AR071653/AR/NIAMS NIH HHS/United States